Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.22.1 (
DNase II
)
429
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The binding of mithramycin to DNA has been investigated using a variety of chemical and enzymic footprinting probes. Mithramycin failed to affect DNA modification by several chemical agents which react in the DNA major groove, suggesting that the drug binds via the minor groove. The pattern of reaction with diethylpyrocarbonate was modified by the antibiotic at the binding site and in surrounding regions, consistent with drug-induced structural changes.
Hydroxyl radical
and DNase I footprinting confirms that the drug binds best to GpG, especially when this is located within a GC-rich environment. Cleavage by
DNase II
and micrococcal nuclease is inhibited around drug binding sites and suggests a local stabilization of the DNA helix.
...
PMID:Footprinting studies of sequence recognition by mithramycin. 215 18